The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.
Park S, Oh AY, Hong BS, Shin YJ, Jang H, Seo H, Kang SM, Woo TG, Park HP, Jeong J, Kim HJ, Kim BH, Kwon Y, Park BJ.
Park S, et al. Among authors: woo tg.
Mol Ther Oncol. 2024 Sep 10;32(4):200875. doi: 10.1016/j.omton.2024.200875. eCollection 2024 Dec 19.
Mol Ther Oncol. 2024.
PMID: 39351074
Free PMC article.